2014 Q2 Form 10-Q Financial Statement
#000110465914035662 Filed on May 07, 2014
Income Statement
| Concept | 2014 Q2 | 2014 Q1 | 2013 Q4 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $5.750M |
| YoY Change | -100.0% | ||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $5.390M | $5.520M | $4.650M |
| YoY Change | 10.22% | 2.22% | -20.51% |
| % of Gross Profit | |||
| Research & Development | $20.06M | $16.87M | $18.05M |
| YoY Change | 3.44% | -16.96% | -8.65% |
| % of Gross Profit | |||
| Depreciation & Amortization | $620.0K | $655.0K | $650.0K |
| YoY Change | -1.59% | -2.09% | 3.17% |
| % of Gross Profit | |||
| Operating Expenses | $25.46M | $16.87M | $22.69M |
| YoY Change | 31.28% | -16.96% | -11.44% |
| Operating Profit | -$22.39M | ||
| YoY Change | -12.93% | ||
| Interest Expense | $70.00K | $80.00K | $80.00K |
| YoY Change | -41.67% | -42.86% | -42.86% |
| % of Operating Profit | |||
| Other Income/Expense, Net | |||
| YoY Change | |||
| Pretax Income | -$25.39M | -$22.30M | -$16.86M |
| YoY Change | 11.51% | -12.79% | -33.8% |
| Income Tax | $0.00 | $0.00 | $0.00 |
| % Of Pretax Income | |||
| Net Earnings | -$25.39M | -$22.30M | -$16.86M |
| YoY Change | 11.51% | -12.79% | -33.8% |
| Net Earnings / Revenue | -293.22% | ||
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$290.1K | -$254.8K | -$192.8K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 87.53M shares | 87.52M shares | 87.43M shares |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2014 Q2 | 2014 Q1 | 2013 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $176.0M | $195.4M | $212.0M |
| YoY Change | -30.05% | -28.29% | -28.92% |
| Cash & Equivalents | $23.90M | $14.91M | $20.85M |
| Short-Term Investments | $152.1M | $180.5M | $191.1M |
| Other Short-Term Assets | $1.500M | $2.400M | $2.400M |
| YoY Change | -48.28% | -20.0% | -42.86% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | $0.00 | $0.00 | $5.750M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $177.5M | $197.8M | $220.1M |
| YoY Change | -30.28% | -28.17% | -27.24% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $3.400M | $3.978M | $4.455M |
| YoY Change | -38.18% | -31.8% | -23.53% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $1.500M | $1.484M | $1.528M |
| YoY Change | -6.25% | -12.76% | -13.13% |
| Total Long-Term Assets | $4.900M | $5.462M | $5.983M |
| YoY Change | -30.99% | -27.12% | -21.12% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $177.5M | $197.8M | $220.1M |
| Total Long-Term Assets | $4.900M | $5.462M | $5.983M |
| Total Assets | $182.4M | $203.3M | $226.1M |
| YoY Change | -30.3% | -28.14% | -27.09% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $1.900M | $1.157M | $3.903M |
| YoY Change | -9.52% | -45.88% | 129.99% |
| Accrued Expenses | $6.700M | $5.400M | $5.200M |
| YoY Change | 24.07% | -12.9% | -46.94% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $10.10M | $7.865M | $10.29M |
| YoY Change | 18.82% | -14.12% | -15.65% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $6.600M | $69.00K | $74.00K |
| YoY Change | -19.51% | -24.18% | -22.92% |
| Total Long-Term Liabilities | $6.600M | $69.00K | $74.00K |
| YoY Change | -19.51% | -24.18% | -22.92% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $10.10M | $7.865M | $10.29M |
| Total Long-Term Liabilities | $6.600M | $69.00K | $74.00K |
| Total Liabilities | $16.70M | $7.934M | $10.37M |
| YoY Change | 0.6% | -14.22% | -15.71% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$871.6M | -$849.3M | |
| YoY Change | 10.91% | 11.71% | |
| Common Stock | $1.060B | $1.057B | |
| YoY Change | 0.84% | 0.78% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $165.7M | $188.3M | $208.3M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $182.4M | $203.3M | $226.1M |
| YoY Change | -30.3% | -28.15% | -27.09% |
Cashflow Statement
| Concept | 2014 Q2 | 2014 Q1 | 2013 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$25.39M | -$22.30M | -$16.86M |
| YoY Change | 11.51% | -12.79% | -33.8% |
| Depreciation, Depletion And Amortization | $620.0K | $655.0K | $650.0K |
| YoY Change | -1.59% | -2.09% | 3.17% |
| Cash From Operating Activities | -$19.94M | -$16.43M | -$18.90M |
| YoY Change | -6.47% | -34.57% | -12.38% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$70.00K | $178.0K | -$170.0K |
| YoY Change | -72.0% | -73.67% | -71.67% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $28.33M | $10.64M | $23.67M |
| YoY Change | 234.87% | -59.79% | -121.98% |
| Cash From Investing Activities | $28.26M | $10.46M | $23.50M |
| YoY Change | 244.63% | -59.44% | -121.7% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $24.00K | ||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 670.0K | 20.00K | 230.0K |
| YoY Change | -18.29% | -99.83% | |
| NET CHANGE | |||
| Cash From Operating Activities | -19.94M | -16.43M | -18.90M |
| Cash From Investing Activities | 28.26M | 10.46M | 23.50M |
| Cash From Financing Activities | 670.0K | 20.00K | 230.0K |
| Net Change In Cash | 8.990M | -5.950M | 4.830M |
| YoY Change | -173.09% | -975.0% | -27.69% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$19.94M | -$16.43M | -$18.90M |
| Capital Expenditures | -$70.00K | $178.0K | -$170.0K |
| Free Cash Flow | -$19.87M | -$16.61M | -$18.73M |
| YoY Change | -5.7% | -35.59% | -10.68% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2014Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
87531317 | shares |
| CY2014Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | |
| CY2014Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
| CY2014Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2014Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2014Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2014Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
| CY2014Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.25in;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">1.</font></b><b><font style="FONT-SIZE: 3pt; FONT-WEIGHT: bold;" size="1">             </font></b> <b><font style="FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Nature of Operations</font></b></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.25in;"> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">We were incorporated in the state of Delaware on June 14, 1996. We are engaged in the discovery and development of novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders.</font></p> </div> | |
| CY2014Q1 | us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.25in;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">2.</font></b><b><font style="FONT-SIZE: 3pt; FONT-WEIGHT: bold;" size="1">             </font></b> <b><font style="FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Basis of Presentation</font></b></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.25in;"> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Our accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP), for interim financial information and pursuant to the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities Act of 1933, as amended (Securities Act). Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These unaudited condensed financial statements include only normal and recurring adjustments that we believe are necessary to fairly state our financial position and the results of our operations and cash flows. Interim-period results are not necessarily indicative of results of operations or cash flows for a full-year or any subsequent interim period. The balance sheet at December 31, 2013 has been derived from audited financial statements at that date, but does not include all disclosures required by U.S. GAAP for complete financial statements. Because all of the disclosures required by U.S. GAAP for complete financial statements are not included herein, these interim unaudited condensed financial statements and the notes accompanying them should be read in conjunction with our audited financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2013.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ from these estimates.</font></p> </div> | |
| CY2014Q1 | rigl |
Share Based Compensation Number Of Stock Option Plans
ShareBasedCompensationNumberOfStockOptionPlans
|
3 | item |
| CY2014Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
18549000 | shares |
| CY2013Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
15855000 | shares |
| CY2014Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2364000 | USD |
| CY2014Q1 | rigl |
Cash And Cash Equivalents And Available For Sale Securities Debt Securities Current
CashAndCashEquivalentsAndAvailableForSaleSecuritiesDebtSecuritiesCurrent
|
195384000 | USD |
| CY2013Q4 | rigl |
Cash And Cash Equivalents And Available For Sale Securities Debt Securities Current
CashAndCashEquivalentsAndAvailableForSaleSecuritiesDebtSecuritiesCurrent
|
211975000 | USD |
| CY2014Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
14910000 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
180474000 | USD |
| CY2014Q1 | rigl |
Cash Equivalents And Available For Sale Securities Amortized Cost
CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost
|
181312000 | USD |
| CY2014Q1 | rigl |
Cash Equivalents And Available For Sale Securities Gross Unrealized Gain
CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGain
|
64000 | USD |
| CY2014Q1 | rigl |
Cash Equivalents And Available For Sale Securities Gross Unrealized Losses
CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLosses
|
26000 | USD |
| CY2014Q1 | rigl |
Cash Equivalents And Available For Sale Securities Debt Securities Unrealized Gain Loss Fair Value Disclosure
CashEquivalentsAndAvailableForSaleSecuritiesDebtSecuritiesUnrealizedGainLossFairValueDisclosure
|
181350000 | USD |
| CY2013Q4 | rigl |
Cash Equivalents And Available For Sale Securities Amortized Cost
CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost
|
202674000 | USD |
| CY2013Q4 | rigl |
Cash Equivalents And Available For Sale Securities Gross Unrealized Gain
CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGain
|
64000 | USD |
| CY2013Q4 | rigl |
Cash Equivalents And Available For Sale Securities Gross Unrealized Losses
CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLosses
|
17000 | USD |
| CY2013Q4 | rigl |
Cash Equivalents And Available For Sale Securities Debt Securities Unrealized Gain Loss Fair Value Disclosure
CashEquivalentsAndAvailableForSaleSecuritiesDebtSecuritiesUnrealizedGainLossFairValueDisclosure
|
202721000 | USD |
| CY2014Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5516000 | USD |
| CY2013Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5395000 | USD |
| CY2014Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
22385000 | USD |
| CY2013Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
25710000 | USD |
| CY2014Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-22385000 | USD |
| CY2013Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-25710000 | USD |
| CY2014Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
82000 | USD |
| CY2013Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
136000 | USD |
| CY2014Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-22303000 | USD |
| CY2013Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-25574000 | USD |
| CY2014Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.25 | |
| CY2013Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.29 | |
| CY2014Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
87526000 | shares |
| CY2013Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
87141000 | shares |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
-9000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
-4000 | USD |
| CY2014Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-22312000 | USD |
| CY2013Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-25578000 | USD |
| CY2014Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
655000 | USD |
| CY2013Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
669000 | USD |
| CY2014Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2364000 | USD |
| CY2013Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1793000 | USD |
| CY2014Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
178000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
676000 | USD |
| CY2013Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1793000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-5750000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
94000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-1262000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-44000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-58000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-2746000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
441000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-374000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-3504000 | USD |
| CY2014Q1 | rigl |
Increase Decrease In Accrued Research And Development Liability
IncreaseDecreaseInAccruedResearchAndDevelopmentLiability
|
724000 | USD |
| CY2013Q1 | rigl |
Increase Decrease In Accrued Research And Development Liability
IncreaseDecreaseInAccruedResearchAndDevelopmentLiability
|
-49000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
-175000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
-69000 | USD |
| CY2014Q1 | rigl |
Increase Decrease In Deferred Rent And Other Long Term Liabilities
IncreaseDecreaseInDeferredRentAndOtherLongTermLiabilities
|
-273000 | USD |
| CY2013Q1 | rigl |
Increase Decrease In Deferred Rent And Other Long Term Liabilities
IncreaseDecreaseInDeferredRentAndOtherLongTermLiabilities
|
-138000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-16428000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-25111000 | USD |
| CY2014Q1 | us-gaap |
Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
|
79637000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
|
100934000 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
90275000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
127396000 | USD |
| CY2014Q1 | rigl |
Cash Equivalents And Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
CashEquivalentsAndAvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
|
152726000 | USD |
| CY2014Q1 | rigl |
Cash Equivalents And Available For Sale Securities Debt Maturities Rolling Year Two Fair Value
CashEquivalentsAndAvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoFairValue
|
28624000 | USD |
| CY2014Q1 | rigl |
Cash Equivalents And Available For Sale Securities Weighted Average Maturity Period
CashEquivalentsAndAvailableForSaleSecuritiesWeightedAverageMaturityPeriod
|
P197D | |
| CY2014Q1 | rigl |
Available For Sale Securities Debt Securities Current Stated Maturity Period May Be Greater Than This Period
AvailableForSaleSecuritiesDebtSecuritiesCurrentStatedMaturityPeriodMayBeGreaterThanThisPeriod
|
P1Y | |
| CY2014Q1 | us-gaap |
Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
|
0 | item |
| CY2014Q1 | us-gaap |
Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
|
31 | item |
| CY2014Q1 | us-gaap |
Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
64463000 | USD |
| CY2014Q1 | rigl |
Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
26000 | USD |
| CY2013Q4 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
191121000 | USD |
| CY2013Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
5750000 | USD |
| CY2014Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
2444000 | USD |
| CY2013Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
2350000 | USD |
| CY2014Q1 | us-gaap |
Assets Current
AssetsCurrent
|
197828000 | USD |
| CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
220075000 | USD |
| CY2014Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3978000 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4455000 | USD |
| CY2014Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
1484000 | USD |
| CY2013Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
1528000 | USD |
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
20854000 | USD |
| CY2014Q1 | us-gaap |
Assets
Assets
|
203290000 | USD |
| CY2013Q4 | us-gaap |
Assets
Assets
|
226058000 | USD |
| CY2014Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2475000 | USD |
| CY2013Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2849000 | USD |
| CY2014Q1 | rigl |
Accrued Research And Development Liability Current
AccruedResearchAndDevelopmentLiabilityCurrent
|
2312000 | USD |
| CY2013Q4 | rigl |
Accrued Research And Development Liability Current
AccruedResearchAndDevelopmentLiabilityCurrent
|
1588000 | USD |
| CY2014Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
571000 | USD |
| CY2013Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
746000 | USD |
| CY2014Q1 | us-gaap |
Deferred Rent Credit Current
DeferredRentCreditCurrent
|
1350000 | USD |
| CY2013Q4 | us-gaap |
Deferred Rent Credit Current
DeferredRentCreditCurrent
|
1208000 | USD |
| CY2014Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
7865000 | USD |
| CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
10294000 | USD |
| CY2014Q1 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
7029000 | USD |
| CY2013Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
7439000 | USD |
| CY2014Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
69000 | USD |
| CY2013Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
74000 | USD |
| CY2014Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1157000 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3903000 | USD |
| CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2014Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2014Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
203290000 | USD |
| CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
226058000 | USD |
| CY2014Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
88000 | USD |
| CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
88000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
25786000 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
24000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
24000 | USD |
| CY2014Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
1059778000 | USD |
| CY2013Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
1057390000 | USD |
| CY2014Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
38000 | USD |
| CY2013Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
47000 | USD |
| CY2014Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-871577000 | USD |
| CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-849274000 | USD |
| CY2014Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
188327000 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
208251000 | USD |
| CY2013Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
| CY2014Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
| CY2014Q1 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
16869000 | USD |
| CY2013Q1 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
20315000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
10460000 | USD |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
33484000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-5944000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
675000 | USD |
| CY2014Q1 | us-gaap |
Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
|
0 | USD |
